BRIEF-Merck KGaA, Darmstadt, Germany licenses four oncology research and development programs from Vertex

* Merck KGaA, Darmstadt, Germany, licenses four oncology research and development programs from Vertex and becomes a leader in DNA damage and repair
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.